These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 24466361

  • 1. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.
    Hasker E, Malaviya P, Gidwani K, Picado A, Ostyn B, Kansal S, Singh RP, Singh OP, Chourasia A, Kumar Singh A, Shankar R, Wilson ME, Khanal B, Rijal S, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2014; 8(1):e2657. PubMed ID: 24466361
    [Abstract] [Full Text] [Related]

  • 2. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
    Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007216. PubMed ID: 30917114
    [Abstract] [Full Text] [Related]

  • 3. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.
    Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, Rijal S, Sundar S, Boelaert M.
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1284. PubMed ID: 21991397
    [Abstract] [Full Text] [Related]

  • 4. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
    Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, Chourasia A, Singh AK, Shankar R, Menten J, Wilson ME, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2013 Oct; 7(2):e2053. PubMed ID: 23459501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.
    Khanal B, Rijal S, Ostyn B, Picado A, Gidwani K, Menten J, Jacquet D, Lejon V, Chappuis F, Boelaert M.
    Trop Med Int Health; 2010 Nov; 15(11):1390-4. PubMed ID: 21998875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
    Bhattacharyya T, Bowes DE, El-Safi S, Sundar S, Falconar AK, Singh OP, Kumar R, Ahmed O, Boelaert M, Miles MA.
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
    [Abstract] [Full Text] [Related]

  • 10. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.
    Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB.
    Am J Trop Med Hyg; 2000 Feb; 63(3-4):153-7. PubMed ID: 11388508
    [Abstract] [Full Text] [Related]

  • 11. Seropositivity of Visceral leishmaniasis on people of VL endemic three districts of Nepal.
    Basnyat S, Banjara MR, Ghimire P, Matlashewski G, Singh A.
    Parasitol Int; 2021 Feb; 80():102236. PubMed ID: 33147500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI, Hossain F, Ghosh P, Chowdhury R, Hossain MS, Jewell C, Cruz I, Picado A, Mondal D, Adams ER.
    Parasit Vectors; 2021 Feb 17; 14(1):111. PubMed ID: 33597000
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.
    Kaushal H, Bhattacharya SK, Verma S, Salotra P.
    Am J Trop Med Hyg; 2017 Jun 17; 96(6):1448-1455. PubMed ID: 28719266
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.
    Khanal B, Picado A, Bhattarai NR, Van Der Auwera G, Das ML, Ostyn B, Davies CR, Boelaert M, Dujardin JC, Rijal S.
    Parasitology; 2010 Sep 17; 137(11):1597-603. PubMed ID: 20459877
    [Abstract] [Full Text] [Related]

  • 20. Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey.
    Cloots K, Uranw S, Ostyn B, Bhattarai NR, Le Rutte E, Khanal B, Picado A, Chappuis F, Hasker E, Karki P, Rijal S, Boelaert M.
    Lancet Glob Health; 2020 Feb 17; 8(2):e237-e243. PubMed ID: 31981555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.